Skip Navigation

Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia and Non-Hodgkin?s Lymphoma

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT03104491

Study #:
STUDY00147659

Start Date:
Apr 17, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03104491

View Complete Trial Details & Eligibility at ClinicalTrials.gov